Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar 5;100(9):e24604.
doi: 10.1097/MD.0000000000024604.

Extra-pulmonary complications of 45 critically ill patients with COVID-19 in Yichang, Hubei province, China: A single-centered, retrospective, observation study

Affiliations
Observational Study

Extra-pulmonary complications of 45 critically ill patients with COVID-19 in Yichang, Hubei province, China: A single-centered, retrospective, observation study

Peng Wang et al. Medicine (Baltimore). .

Abstract

Mortality of critically ill patients with coronavirus disease 2019 (COVID-19) was high. Aims to examine whether time from symptoms onset to intensive care unit (ICU) admission affects incidence of extra-pulmonary complications and prognosis in order to provide a new insight for reducing the mortality. A single-centered, retrospective, observational study investigated 45 critically ill patients with COVID-19 hospitalized in ICU of The Third People's Hospital of Yichang from January 17 to March 29, 2020. Patients were divided into 2 groups according to time from symptoms onset to ICU admission (>7 and ≤7 days) and into 2 groups according to prognosis (survivors and non-survivors). Epidemiological, clinical, laboratory, radiological characteristics and treatment data were studied. Compared with patients who admitted to the ICU since symptoms onset ≤7 days (55.6%), patients who admitted to the ICU since symptoms onset >7 days (44.4%) were more likely to have extra-pulmonary complications (19 [95.0%] vs 16 [64.0%], P = .034), including acute kidney injury, cardiac injury, acute heart failure, liver dysfunction, gastrointestinal hemorrhage, hyperamylasemia, and hypernatremia. The incidence rates of acute respiratory distress syndrome, pneumothorax, and hospital-acquired pneumonia had no difference between the 2 groups. Except activated partial thromboplastin and Na+ concentration, the laboratory findings were worse in group of time from symptoms onset to ICU admission >7 days. There was no difference in mortality between the 2 groups. Of the 45 cases in the ICU, 19 (42.2%) were non-survivors, and 16 (35.6%) were with hospital-acquired pneumonia. Among these non-survivors, hospital-acquired pneumonia was up to 12 (63.2%) besides higher incidence of extra-pulmonary complications. However, hospital-acquired pneumonia occurred in only 4 (15.4%) survivors. Critically ill patients with COVID-19 who admitted to ICU at once might get benefit from intensive care via lower rate of extra-pulmonary complications.

PubMed Disclaimer

Conflict of interest statement

All the authors state that there are no conflicts of interest related to this study.

Figures

Figure 1
Figure 1
Chest computed tomographic images of 2 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). (A–C) CT images obtained in a 54-year-old woman on day 9 after symptom onset, show ground glass opacity and consolidation in both lungs. (D–F) CT images obtained in a 68-year-old man on day 5 after symptom onset, show ground glass opacity and consolidation in peripheral areas. Both patients were diagnosed ARDS with low ratio of PaO2 to FiO2: 57.0 and 88.0 mmHg, respectively. Written informed consent was provided by the 2 patients.
Figure 2
Figure 2
Comparison between the incidence rates of hospital-acquired pneumonia, extra-pulmonary complications, and acute respiratory distress syndrome of survivors and non-survivors. ∗, # mean P < .05.

Similar articles

Cited by

References

    1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506. - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33. - PMC - PubMed
    1. Wang D, Hu B, Hu C, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–9. - PMC - PubMed
    1. Liu X, Zhang S. COVID-19: face masks and human-to-human transmission. Influenza Other Respir Viruses 2020;14:472–3. - PMC - PubMed
    1. Mu A. A COVID-19 transmission within a family cluster by presymptomatic infectors in China. J Chem Inf Model 2019;53:1689–99.

Publication types

MeSH terms